Company
JRNYS
JRNYS publishes brand semaglutide, brand tirzepatide and compounded tirzepatide, from $25 to $216 a month.
- 3 programs
- 3 molecules
- 3 readings
Read from jrnys.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to JRNYS
We earn nothing from this link. JRNYS has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · ◯ $25 advertised · Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership)
first month, including the required fees on record · ◯ $25 advertised · Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership)
first month, including the required fees on record · ◯ $216 advertised · Compounded Tirzepatide Microdose, cash pay, all-inclusive (not the brand-Mounjaro/Zepbound path above)
Terms
| Membership | Required, $89 per month. Start for $89/month* *Does not include the cost of medication. ... Membership ranges from $89 per month to $169 per month depending on your level of 1-1 coach support. The base price includes your medical visits, daily monitoring, coaching & access to member exclusive content. |
|---|
Not yet checked: pharmacy, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
| Entry | Provider | Per month at its shortest term | Link |
|---|---|---|---|
| TR-0803 | JRNYS | $25 Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership) | Record |
| TR-0804 | JRNYS | $25 Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership) | Record |
| TR-0805 | JRNYS | $216 Compounded Tirzepatide Microdose, cash pay, all-inclusive (not the brand-Mounjaro/Zepbound path above) | Record |
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Textbook membership trap: the headline '$89/month' figure repeated across the whole site is explicitly footnoted '*Does not include the cost of medication' and confirmed on product pages as a $89-$169/mo membership fee only. JRNYS sells brand-name GLP-1s (Ozempic, Mounjaro, Zepbound, Wegovy) via insurance navigation, for which the only price given is an insurance-capped '$25 per month after any deductible is met' (an insurance price, recorded separately per the brief's rule) — no cash price for the brand path is published. Separately, JRNYS also sells a 'Compounded Tirzepatide Microdose' product at a flat 'from $216/m' cash price, framed as inclusive ('Compounded medications are not FDA-approved... prepared by licensed pharmacies'); this is NOT the same product as the branded Mounjaro/Zepbound path and is recorded as its own entry. Also found a real self-contradiction: the Cancellation Policy page says 'your initial telehealth fee of $89 will not be refunded,' while the Terms & Conditions page says 'your initial telehealth fee of $35 will not be refunded' for the same fee — flagged, not resolved. No page stating served states was found. Footer legal text names a 'KINSYN' brand ('KINSYN provides clinician-guided wellness and metabolic health programs') alongside JRNYS, suggesting a shared backend across brands.
Before you act
Cite this
Treatment Registry. (2026). JRNYS: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/jrnys